CODX Co-Diagnostics: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Co-Diagnostics - graphic logo of issuer CODX

The EV/EBITDA price dynamics history for Co-Diagnostics, Inc. (CODX), whose operations rely on laboratory diagnostics, currently stands at 0.00. Co-Diagnostics, Inc. (CODX) is developing a network of B2B partnerships for the rapid detection of pathogens. The implementation of advanced molecular analysis systems for clinics and the private sector is expanding the range of available tests. An impeccable image and high research accuracy have established the brand as a global benchmark in the PCR field.

Co-Diagnostics Corp - CODX Total Company Value to Operating Income Before Depreciation Ratio (period 11/23/2025 - 11/12/2026)

Summary analytical data breakdowns for codiagnostics.com (CODX)

- stock price and consensus target price:
Stock Quotes Co-Diagnostics Corp|CODX - Average Forecast Price
- company stock capitalization data:
Market Value CoDx|CODX - Company Buyout Price
- book value of equity indicators:
Book Value per Share Co-Diagnostics|CODX - Book Valuation of Business|Market Value to Book Value Ratio codiagnostics.com|CODX - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Capital Co-Diagnostics, Inc.|CODX - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Co-Diagnostics|CODX - Company Cumulative Debt|Debt to Book Value CoDx|CODX - Long-Term Indebtedness|Company Short-Term Debts Co-Diagnostics|Quick Ratio codiagnostics.com
- financial results and valuation multiples details:
CODX - Net Financial Result|Projected Future Earnings Co-Diagnostics, Inc.|CODX - P/E Multiple|Forward P/E Multiple Co-Diagnostics, Inc.|CODX - Price to Net Income Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CoDx|CODX - Operating profit before amortization|Earnings per share for the last twelve months Co-Diagnostics|CODX - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months codiagnostics.com|CODX - Expected net earnings per share growth this year|Expected earnings per share growth for next year Co-Diagnostics, Inc.
Initial company analysis:Co-Diagnostics Corp (CODX)
Product sample of Co-Diagnostics

The commercialization of molecular diagnostic technologies requires significant capital expenditures, making debt load control critically important for Co-Diagnostics, Inc. (CODX). By analyzing the EV/EBITDA enterprise value multiple over time, an investor correlates the total value of assets, including debt, with operating profit to determine the issuer's ability to generate cash flow: undervalued figures signal a risk of default, while overvalued ones indicate an overpayment for the asset.

Main competitors

Agilent Tech - Enterprise Value to EBITDA Ratio|Quest Corp (DGX) - Company Value to EBITDA|ILMN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|RVTY: EV/EBITDA Multiple|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anbio Tech|Nordion (SHC) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple QDEL|Enterprise Value to EBITDA Ratio opko.com OPK|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CareDx Inc CDNA|Maravai LifeSciences Holdings (MRVI) - Company Value to EBITDA|FLGT: Enterprise Value to EBITDA Ratio|Enterprise Value to EBITDA Multiple Standard BioTools Corp (LAB)|CTKB: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OSUR|XGN (Exagen Inc) - EV/EBITDA Multiple|MDxHealth S.A. (MDXH) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple LUCD|EV/EBITDA Multiple prenetics.com (PRE)|EV/EBITDA Multiple IMDX (Insight Molecular Diagnostics Inc)|Enterprise Value to EBITDA Multiple Trinity Biotech PLC|PRPH - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AIMD (Ainos Inc) - Enterprise Value to Operating Income Before Depreciation|Heart Test Laboratories Inc. (HSCS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Biomerica Inc (BMRA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cardio Diagnostics Holdings Inc.|onconetix.gcs-web.com (ONCO) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio VRAX (Virax Biolabs)|Enterprise Value to Operating Income Before Depreciation Ratio BJDX|EV/EBITDA Multiple AWH (Vermillion)|Total Company Value to Operating Income Before Depreciation Ratio Accelerate Diagnostics Inc (AXDX)|CENTOGENE, N.V. - EV/EBITDA Multiple|Enzo Biochem, Inc. (ENZ) - Enterprise Value to EBITDA Ratio|fresh2.co (FRES) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GENE - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio ME|PMD: Business Value to Operating Income Before Depreciation